Regeneron and Bayer Report Positive Results for VEGF Trap-Eye in Phase 3 Study in Central Retinal Vein Occlusion (CRVO) and in Phase 2 Study in Diabetic Macular Edema (DME) - Drugs.com MedNews
Links shared publicly online about this topic.
- 641total visits
Regeneron and Bayer Report Positive Results for VEGF Trap-Eye in Phase 3 Study in Central Retinal Vein Occlusion (CRVO) and in Phase 2 Study in Diabetic Macular Edema (DME) - Drugs.com MedNews
In Phase 3 study in CRVO, 56 percent of VEGF Trap-Eye patients gained at least 15 letters of vision compared to 12 percent in control group VEGF Trap-Eye patien
View full resource at drugs.com
Tags: Circulation, Edema, Diabetes, Drug, Phase 2 Clinical Trial, Phase 3 Clinical Trial, Bayer
Most Recently Shared on December 20, 2010 at 3:01 pm By:
Regeneron and Bayer Report Positive Results for VEGF Trap-Eye in Phase 3 Study in Central Retinal Vein Occ... http://bit.ly/gsAHQw #drug
Advertisement
